GcMAF

Gc protein-derived macrophage activating factor (GcMAF) is a proposed macrophage-activating immunotherapy linked to cancer through the vitamin D-binding protein/nagalase hypothesis. The cancer record is controversial and disputed: it includes lab and animal studies, small human reports, retractions, critiques, regulatory actions, and ongoing claims from proponents.